Zura Bio Ltd (ZURA) stock
ZURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.93−0.02 (-2.30%)
Close on Nov 20, 2026Market cap $89.63MP/E –Yield –
Zura Bio operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Zura Bio's operating cash flow for the twelve months ending Sep 30, 2026 was -$64.83M. For fiscal 2025 it was -$64.82M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$64.82M | – |
| FY2024 | Dec 31, 2024 | -$28.08M | – |
| FY2023 | Dec 31, 2023 | -$15.05M | – |
| FY2022 | Dec 31, 2022 | -$1.07M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$19.50K | – |
| Q2 FY2026 | Jun 30, 2026 | $18.88M | +71.1% |
| Q1 FY2026 | Mar 31, 2026 | -$18.92M | – |
| Q4 FY2025 | Dec 31, 2025 | -$64.77M | – |
| Q3 FY2025 | Sep 30, 2025 | -$15.44K | – |
| Q2 FY2025 | Jun 30, 2025 | $11.04M | – |
| Q1 FY2025 | Mar 31, 2025 | -$11.06M | – |
| Q4 FY2024 | Dec 31, 2024 | -$10.82M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.65M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.62M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.98M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.05M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.57M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.17M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.26M | – |
| Q4 FY2022 | Dec 31, 2022 | -$116.28K | – |
| Q3 FY2022 | Sep 30, 2022 | -$267.26K | – |
| Q2 FY2022 | Jun 30, 2022 | -$472.88K | – |
| Q1 FY2022 | Mar 31, 2022 | -$214.62K | – |
See a number that looks wrong?